Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
32.43
-2.30 (-6.62%)
Mar 31, 2025, 9:47 AM EDT - Market open
Crinetics Pharmaceuticals Revenue
In the year 2024, Crinetics Pharmaceuticals had annual revenue of $1.04M, down -74.11%.
Revenue (ttm)
$1.04M
Revenue Growth
-74.11%
P/S Ratio
3,110.28
Revenue / Employee
$2,378
Employees
437
Market Cap
3.02B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CRNX News
- 3 days ago - Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly - GlobeNewsWire
- 20 days ago - Crinetics Pharmaceuticals Announces March 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Crinetics Pharmaceuticals, Inc (CRNX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer - GlobeNewsWire
- 5 weeks ago - Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences - GlobeNewsWire
- 6 weeks ago - Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewsWire